WAYNE, Pa., Sept. 5, 2013 /PRNewswire/ -- Ryan &
Maniskas, LLP is investigating potential claims against the board
of directors of Rochester Medical Corporation ("Rochester Medical"
or the "Company") (NASDAQ: ROCM) concerning possible breaches of
fiduciary duty and other violations of law related to the Company's
efforts to sell the Company to C.R. Bard, Inc. in a transaction
valued at approximately $262
million.
(Logo: http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
)
Under the terms of the agreement, shareholders of Rochester
Medical will receive $20.00 per share
in cash for each share of Rochester Medical they own.
If you own shares of Rochester Medical and would like to learn
more about these claims or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/rocm. You may also email Mr.
Maniskas at rmaniskas@rmclasslaw.com.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by Rochester Medical's Board of
Directors for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT: Ryan & Maniskas,
LLP
Richard
A. Maniskas,
Esquire
995
Old Eagle School Rd., Suite
311
Wayne,
PA
19087
877-316-3218
www.rmclasslaw.com/cases/rocm
rmaniskas@rmclasslaw.com
SOURCE Ryan & Maniskas, LLP